scholarly journals P007: Cunningham reduction of anterior shoulder dislocation facilitated by inhaled low-dose methoxyflurane – a pilot study

CJEM ◽  
2020 ◽  
Vol 22 (S1) ◽  
pp. S66-S67
Author(s):  
H. Wiemer ◽  
S. Campbell ◽  
R. Fitzpatrick ◽  
C. Carriere ◽  
S. Teed ◽  
...  

Introduction: The Cunningham reduction method for anterior shoulder dislocation offers an atraumatic alternative to traditional reduction techniques without the inconvenience and risk of procedural sedation and analgesia (PSA). Unfortunately, success rates as low as 27% have limited widespread use of this method. Inhaled methoxyflurane (I-MEOF) offers a rapidly administered, minimally invasive option for short-term analgesia. We conducted a pilot study to evaluate the feasibility of studying whether I-MEOF increased success rates for atraumatic reduction of anterior shoulder dislocation. Methods: A convenience sample of 20 patients with uncomplicated anterior shoulder dislocations were offered the Cunningham reduction method supported by methoxyflurane analgesia under the guidance of an advanced care paramedic. Operators were instructed to limit their attempt to the Cunningham method. Outcomes included success rate without the requirement for PSA, time to discharge, and operator and patient satisfaction with the procedure. Results: 20 patients received I-MEOF and an attempt at Cunningham reduction. 80% of patients were male, median age was 38.6 (range 18-71), and 55% were first dislocations of that joint. 35% (8/20 patients) had reduction successfully achieved by the Cunningham method under I-MEOF analgesia. The remainder proceeded to closed reduction under PSA. All patients had eventual successful reduction in the ED. 60% of operators reported good to excellent satisfaction with the process, with inadequate muscle relaxation being identified as the primary cause of failed initial attempts. 80% of patients reported good to excellent satisfaction. Conclusion: Success with the Cunningham technique was marginally increased with the use of I-MEOF, although 65% of patients still required PSA to facilitate reduction. The process was generally met with satisfaction by both providers and patients, suggesting that early administration of analgesia is appreciated. Moreover, one-third of patients had reduction achieved atraumatically without need for further intervention. A larger, randomized study may identify patient characteristics which make this reduction method more likely to be successful.

2020 ◽  
Vol 23 (5) ◽  
pp. 295-301
Author(s):  
Joseph T. Fennelly ◽  
Lysander Gourbault ◽  
Gregory Neal-Smith ◽  
Akhilesh Pradhan ◽  
Venkat Gade ◽  
...  

2015 ◽  
Vol 33 (2) ◽  
pp. 294-297
Author(s):  
Feriyde Çalışkan Tür ◽  
Özge Duman Atilla ◽  
Zeynep Temizyürek ◽  
Murat Yeşilaras ◽  
Ersin Aksay

2003 ◽  
Vol 13 (2) ◽  
pp. 164-169
Author(s):  
R. Yazigi ◽  
G. Aliste ◽  
R. Torres ◽  
A. M. Ciudad ◽  
M. Cuevas ◽  
...  

This randomized pilot study was designed to determine whether the addition of interferon α-2b to standard radiation therapy offered an advantage in loco-regional control and survival over radiation therapy alone in a homogeneous group of patients with stage IIIB carcinoma of the cervix. Thirty-six patients were treated with a combination of interferon α-2b plus radiation therapy, and 38 patients were treated with radiation therapy alone. Patients with evidence of ureteral obstruction were excluded from the study. Evaluation of loco-regional response was determined by pelvic examination, cervical cytology, biopsies and CT scans when indicated. Survival time was measured from initiation of treatment to date of death or last follow-up. Patient characteristics were comparable between both study arms. The objective complete response rate was 67% in the combined therapy group and 55% in the radiation alone group (P = 0.454). With a median follow-up of 17 months for all patients and 31 months for live patients, 50% of the combined group survived vs. 39.5% of the radiation alone group (P = 0.424). We conclude that the addition of interferon α-2b to standard radiation therapy did not significantly improve loco-regional response or survival, although such a trend was noted. We encourage the design of a larger randomized study with sufficient power to detect meaningful differences to prove whether the tendency observed in the present investigation holds any promise to improve the outcome of these patients.


2021 ◽  
pp. 180-184
Author(s):  
Steven Johannes Georg Leeuwerke ◽  
Martine Christine Keuning ◽  
Jan Willem Ek ◽  
Jan van Beveren

Bilateral anterior shoulder dislocation is rare. We describe the case of a 21-year-old male with bilateral anterior shoulder dislocation following a nocturnal, hypoglycemia-induced convulsion. The relatively uncommon Boss-Holzach-Matter technique provides an easy, atraumatic, and time-efficient self-reduction method to achieve simultaneous reduction of bilateral anterior shoulder dislocation, without the need for anesthesia or analgesia.


Sign in / Sign up

Export Citation Format

Share Document